Filters

Prakash R Sista, Tom Melby, Donna Davison, Lei Jin, Sarah Mosier, Mike Mink, Emily L Nelson, Ralph DeMasi, Nick Cammack, Miklos P Salgo, Tom J Matthews, Michael L Greenberg

AIDS (London, England) 2004;18(13):1787-94

Full Text

Abstract

Origins of resistance to the HIVgp41 viral entry inhibitor T20.

Brian E McGillick, Trent E Balius, Sudipto Mukherjee, Robert C Rizzo

Biochemistry 2010;49(17):3575-92

Free Full Text

Abstract

Results: 1 – 15 / 57

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""HIV Fusion Inhibitors""[mesh_terms]

Qadirvirtide.

Enfuvirtide, a new fusion inhibitor for therapy of human immunodeficiency virus infection.

Inhibitors of HIV-1 entry.

Novel anti-viral therapy: drugs that block HIV entry at different target sites.

Synthesized peptide inhibitors of HIV-1 gp41-dependent membrane fusion.

Heptad-repeat-2 mutations enhance the stability of the enfuvirtide-resistant HIV-1 gp41 hairpin structure.

Resistance to enfuvirtide, the first HIV fusion inhibitor.

The current status and challenges in the development of fusion inhibitors as therapeutics for HIV-1 infection.

HIV fusion inhibitors.

Peptide-Based Dual HIV and Coronavirus Entry Inhibitors.

HIV-1 Envelope Spike MPER: From a Vaccine Target to a New Druggable Pocket for Novel and Effective Fusion Inhibitors.

Enfuvirtide, the first fusion inhibitor to treat HIV infection.

Targeting CXCR4 in HIV cell-entry inhibition.

Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.

Origins of resistance to the HIVgp41 viral entry inhibitor T20.

Results for
""HIV Fusion Inhibitors""[mesh_terms]